Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia Journal Article


Authors: Lamanna, N.; Weiss, M. A.
Article Title: Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia
Keywords: fludarabine; clinical trial; neutropenia; cancer combination chemotherapy; drug dose reduction; drug efficacy; rituximab; flow cytometry; multiple cycle treatment; bone marrow suppression; thrombocytopenia; cyclophosphamide; enzyme linked immunosorbent assay; febrile neutropenia; pneumonia; fluorescence in situ hybridization; drug response; short survey; drug dose increase; chronic lymphatic leukemia; bone marrow examination
Journal Title: Current Hematologic Malignancy Reports
Volume: 4
Issue: 4
ISSN: 1558-8211
Publisher: Springer  
Date Published: 2009-10-01
Start Page: 185
End Page: 186
Language: English
DOI: 10.1007/s11899-009-0034-1
PROVIDER: scopus
PUBMED: 20425406
DOI/URL:
Notes: --- - "Export Date: 30 November 2010" - "Source: Scopus"
Altmetric Score
MSK Authors
  1. Nicole Lamanna
    57 Lamanna
  2. Mark Weiss
    80 Weiss